Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clarient
Clarient receives notice of potential delisting from Nasdaq
August 13th, 2006
Clarient, Inc. (CLRT), a technology and services resource for pathologists, oncologists and the pharmaceutical industry, announced that the company received a notice from the Nasdaq Listing Qualification Staff that the company's common stock is subject to delisting from the Nasdaq Capital Market as a result of failure to comply with the $1.00 per share bid price requirement for 30 consecutive days as required by Nasdaq Marketplace Rule 4310(c)(4). In accordance with Nasdaq Marketplace Rule 4310(c)(8)(D), the company will be provided 180 calendar days, or until January 8, 2007, to regain compliance. If at any time before January 8, 2007, the bid price of the company's...
Source: Health Insurance Law Weekly (2006-08-13)
|
